| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 产品1(元) | 32,339,600.78 | 66,014,570.82 | 33,295,610.13 |
| 产品4(元) | - | - | 13,109.73 |
| 胆固醇(元) | - | - | 178,982.30 |
| 非那甾胺中间体(元) | 19,420,909.33 | 53,705,308.09 | 26,357,446.66 |
| 甲基吡啶(元) | 56,590,476.11 | 131,586,325.92 | 115,198,926.07 |
| 木苦甾酮(元) | 1,202,376.10 | 2,938,422.72 | 71,632.73 |
| 营业成本(元) | |||
| 产品1(元) | 3,674,205.66 | 7,376,206.60 | 3,330,614.82 |
| 产品4(元) | - | - | 3,803.88 |
| 胆固醇(元) | - | - | 176,046.14 |
| 非那甾胺中间体(元) | 12,080,110.13 | 36,861,167.90 | 16,323,391.48 |
| 甲基吡啶(元) | 22,784,508.52 | 45,992,117.84 | 31,751,543.33 |
| 木苦甾酮(元) | 311,037.52 | 1,293,255.68 | 52,924.78 |
| 毛利(元) | |||
| 产品1(元) | 28,665,395.12 | 58,638,364.22 | 29,964,995.31 |
| 产品4(元) | - | - | 9,305.85 |
| 胆固醇(元) | - | - | 2,936.16 |
| 非那甾胺中间体(元) | 7,340,799.20 | 16,844,140.19 | 10,034,055.18 |
| 甲基吡啶(元) | 33,805,967.59 | 85,594,208.08 | 83,447,382.74 |
| 木苦甾酮(元) | 891,338.58 | 1,645,167.04 | 18,707.95 |
| 毛利率(%) | |||
| 产品1(%) | 88.64 | 88.83 | 90.00 |
| 产品4(%) | - | - | 70.98 |
| 胆固醇(%) | - | - | 1.64 |
| 非那甾胺中间体(%) | 37.80 | 31.36 | 38.07 |
| 甲基吡啶(%) | 59.74 | 65.05 | 72.44 |
| 木苦甾酮(%) | 74.13 | 55.99 | 26.12 |
| 收入构成(%) | |||
| 产品1(%) | 29.52 | 25.96 | 19.01 |
| 产品4(%) | - | - | 0.01 |
| 胆固醇(%) | - | - | 0.10 |
| 非那甾胺中间体(%) | 17.73 | 21.12 | 15.05 |
| 甲基吡啶(%) | 51.66 | 51.76 | 65.78 |
| 木苦甾酮(%) | 1.10 | 1.16 | 0.04 |
| 毛利构成(%) | |||
| 产品1(%) | 40.54 | 36.04 | 24.27 |
| 产品4(%) | - | - | 0.01 |
| 胆固醇(%) | - | - | 0.00 |
| 非那甾胺中间体(%) | 10.38 | 10.35 | 8.13 |
| 甲基吡啶(%) | 47.81 | 52.60 | 67.58 |
| 木苦甾酮(%) | 1.26 | 1.01 | 0.02 |